Ensartinib in advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, two-staged, phase 1 trial.
Ma Y, Pan H, Liu Y, Zhang Y, Hong S, Huang J, Weng S, Yang Y, Fang W, Huang Y, Xiao S, Wang T, Ding L, Cui L, Zhang L, Zhao H.
Ma Y, et al. Among authors: cui l.
J Thorac Dis. 2022 Dec;14(12):4751-4762. doi: 10.21037/jtd-22-1606.
J Thorac Dis. 2022.
PMID: 36647478
Free PMC article.